Literature DB >> 19727133

The developmental stage determines the distribution and duration of gene expression after early intra-amniotic gene transfer using lentiviral vectors.

M Endo1, T Henriques-Coelho, P W Zoltick, D H Stitelman, W H Peranteau, A Radu, A W Flake.   

Abstract

Gene transfer after intra-amniotic injection has, in general, been of low efficiency and limited to epithelial cells in the skin, pulmonary and gastrointestinal system. We have recently shown that early gestational administration results in a more efficient gene transfer to developmentally accessible stem cell populations in the skin and eye. In this study we present a comprehensive analysis of patterns of tissue expression seen after early intra-amniotic gene transfer (IAGT) using lentiviral vectors. To assess the influence of developmental stage on tissue expression, injections were administered from the late head fold/early somite stage (E8) to E18. In early gestation (E8-10), green fluorescent protein (GFP) expression was observed in multiple organs, derived from all three germ layers. Remarkably, GFP expression was observed in tissues derived from mesoderm and neural ectoderm at E8, whereas expression was limited to only epithelial cells of ectoderm- and endoderm-derived organs after E11. The amount and duration of gene expression was much higher after IAGT at early gestational time points. The observed temporal patterns of gene expression correspond to the predicted developmental accessibility of organ-specific cell populations. This model may be useful for the analyses of mechanisms of genetic and/or developmental disease and for the development of prenatal gene therapy for specific disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19727133     DOI: 10.1038/gt.2009.115

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  17 in total

1.  Early intra-amniotic gene transfer using lentiviral vector improves skin blistering phenotype in a murine model of Herlitz junctional epidermolysis bullosa.

Authors:  M Endo; P W Zoltick; A Radu; Q Jiang; J Qiujie; C Matsui; P M Marinkovich; J McGrath; K Tamai; J Uitto; A W Flake
Journal:  Gene Ther       Date:  2011-09-22       Impact factor: 5.250

2.  Life-Long Transgene Expression in Skeletal Muscle Without Transduction of Satellite Cells Following Embryonic Myogenic Progenitor Transduction by Lentivirus Administered in Utero.

Authors:  David H Stitelman; Tim R Brazelton; Masayuki Endo; Archana Bora; Jeremy Traas; Philip W Zoltick; Alan W Flake
Journal:  Stem Cells Dev       Date:  2015-06-09       Impact factor: 3.272

3.  Robust in vivo transduction of nervous system and neural stem cells by early gestational intra amniotic gene transfer using lentiviral vector.

Authors:  David H Stitelman; Masayuki Endo; Archana Bora; Nidal Muvarak; Philip W Zoltick; Alan W Flake; Timothy R Brazelton
Journal:  Mol Ther       Date:  2010-06-22       Impact factor: 11.454

4.  Genetic modification of airway progenitors after lentiviral gene delivery to the amniotic fluid of murine fetuses.

Authors:  Suparna Mishra; Xingchao Wang; Nancy Smiley; Ping Xia; Chang Mu Hong; Dinithi Senadheera; Kim Chi Bui; Carolyn Lutzko
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-25       Impact factor: 6.914

5.  In utero gene editing for monogenic lung disease.

Authors:  Deepthi Alapati; William J Zacharias; Heather A Hartman; Avery C Rossidis; John D Stratigis; Nicholas J Ahn; Barbara Coons; Su Zhou; Hiaying Li; Kshitiz Singh; Jeremy Katzen; Yaniv Tomer; Alexandra C Chadwick; Kiran Musunuru; Michael F Beers; Edward E Morrisey; William H Peranteau
Journal:  Sci Transl Med       Date:  2019-04-17       Impact factor: 17.956

6.  Intra-amniotic transient transduction of the periderm with a viral vector encoding TGFβ3 prevents cleft palate in Tgfβ3(-/-) mouse embryos.

Authors:  Chadwick Wu; Masa Endo; Byung H Yang; Melissa A Radecki; Patrick F Davis; Philip W Zoltick; Ryan M Spivak; Alan W Flake; Richard E Kirschner; Hyun-Duck Nah
Journal:  Mol Ther       Date:  2012-10-23       Impact factor: 11.454

7.  In utero lung gene transfer using adeno-associated viral and lentiviral vectors in mice.

Authors:  Luc Joyeux; Enrico Danzer; Maria P Limberis; Philip W Zoltick; Antoneta Radu; Alan W Flake; Marcus G Davey
Journal:  Hum Gene Ther Methods       Date:  2014-04-21       Impact factor: 2.396

Review 8.  Delivery technologies for in utero gene therapy.

Authors:  Rohan Palanki; William H Peranteau; Michael J Mitchell
Journal:  Adv Drug Deliv Rev       Date:  2020-11-09       Impact factor: 15.470

Review 9.  A narrative review of in utero gene therapy: advances, challenges, and future considerations.

Authors:  Nicholas K Yung; Nathan L Maassel; Sarah J Ullrich; Adele S Ricciardi; David H Stitelman
Journal:  Transl Pediatr       Date:  2021-05

10.  In utero adenine base editing corrects multi-organ pathology in a lethal lysosomal storage disease.

Authors:  Sourav K Bose; Brandon M White; Meghana V Kashyap; Apeksha Dave; Felix R De Bie; Haiying Li; Kshitiz Singh; Pallavi Menon; Tiankun Wang; Shiva Teerdhala; Vishal Swaminathan; Heather A Hartman; Sowmya Jayachandran; Prashant Chandrasekaran; Kiran Musunuru; Rajan Jain; David B Frank; Philip Zoltick; William H Peranteau
Journal:  Nat Commun       Date:  2021-07-13       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.